Lipoprotein associated- phospholipase A2 in STEMI vs. NSTE-ACS patients: a marker of cardiovascular atherosclerotic risk rather than thrombosis
Conclusion: The present study shows that among ACS patients, the levels of Lp-PlA2 are inversely associated with STEMI presentation and thrombotic coronary occlusion, being instead increased in NSTE-ACS patients, therefore potentially representing a marker of more aggressive chronic cardiovascular disease with an increased risk of recurrent cardiovascular events.
Source: Journal of Thrombosis and Thrombolysis - Category: Hematology Source Type: research
More News: Angiography | Cardiology | Cardiovascular | Cholesterol | Clopidogrel | Heart | Heart Attack | Hematology | Hypertension | Plavix | Statin Therapy | Study | Thrombosis